1. Home
  2. IOT vs JAZZ Comparison

IOT vs JAZZ Comparison

Compare IOT & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Samsara Inc.

IOT

Samsara Inc.

N/A

Current Price

$32.99

Market Cap

18.5B

Sector

Technology

ML Signal

N/A

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$254.09

Market Cap

15.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOT
JAZZ
Founded
2015
2003
Country
United States
Ireland
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.5B
15.6B
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
IOT
JAZZ
Price
$32.99
$254.09
Analyst Decision
Buy
Strong Buy
Analyst Count
12
14
Target Price
$45.42
$217.57
AVG Volume (30 Days)
5.3M
659.5K
Earning Date
06-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
92.86
N/A
EPS
0.08
4.43
Revenue
$1,618,635,000.00
$1,618,693,000.00
Revenue This Year
$23.00
$6.22
Revenue Next Year
$19.69
$7.68
P/E Ratio
$393.63
$57.53
Revenue Growth
29.57
N/A
52 Week Low
$23.38
$105.00
52 Week High
$47.47
$255.20

Technical Indicators

Market Signals
Indicator
IOT
JAZZ
Relative Strength Index (RSI) 44.29 62.37
Support Level $28.31 $222.49
Resistance Level $35.70 N/A
Average True Range (ATR) 2.27 7.52
MACD -0.60 0.84
Stochastic Oscillator 19.41 86.30

Price Performance

Historical Comparison
IOT
JAZZ

About IOT Samsara Inc.

Samsara Inc provides an end-to-end solution for operations. The company's Connected Operations Platform consolidates data from its IoT devices and a growing ecosystem of connected assets and third-party systems, and makes it easy for organizations to access, analyze, and act on data insights using its cloud dashboard, custom alerts and reports, mobile apps, and workflows. The company derives almost all of its revenue from subscription services. Geographically, it derives a majority of its revenue from the United States. The company's customers range from small and medium-sized businesses to state and local governments.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: